Patients with type 2 diabetes who had eating problems and higher levels of diabetes distress had worse time-in-range.

Wolters Kluwer Health conducted a survey of just over 1000 respondents to get US adults’ feelings about notable trends in the pharmacy industry.

Researchers aimed to determine the frequency of pain assessments and the extent of pain scores by age for patients undergoing traumatic surgery.

Investigators said there is an imperative to optimize medication utilization and explore the consequences of medication burden on treatment outcomes in patients with long COVID.

Adam J. James, PharmD, joined Drug Topics to discuss his career journey as a chain pharmacist.

Researchers evaluated the efficacy of a self-managed intervention vs enhanced usual care.

Researchers analyzed the impact of the COVID-19 pandemic on outcomes for patients with pancreatic cancer living in England.

A PDUFA date for acoramidis has been set for November 29, 2024.

Drug Topics sat down with Adam J. James, PharmD, to discuss his journey from chain pharmacist to innovation leader at Rite Aid."

Continued methylphenidate or atomoxetine use may be safe, but additional studies are needed.

A conversation with Trent Thiede, PharmD, MBA, president of PAAS National, at NCPA 2024.

After shared decision making with their community pharmacist, patients were more likely to receive an RSV vaccine.

As “therapeutic orphans,” pregnant women and their health care providers must balance the benefits of treatment with the risk of fetal harm.

Pharmacy experts from AON Pharmacy in Florida discussed the Inflation Reduction Act and how it affects reimbursement for Medicare Part D drugs.

A study found that a continuous glucose monitor workflow led by a pharmacist led to reduced HbA1c levels.

Cassandra Esperant, PharmD, AAHIVP, discussed the ups and downs of her career journey as a clinical HIV pharmacist.

A conversation with AJ Loiacono, co-founder and CEO of Capital RX, at NCPA 2024.

Researchers compared the racial and ethnic representation of participants in food allergen trials with patients who experience food allergies.

Selina Coleman, JD, Partner in Life Sciences Health Industry Group at Reed Smith LLP, discussed recent developments in Supreme Court decisions impacting pharmacy operations.

The data from PURPOSE 2 will be published in The New England Journal of Medicine.

An FDA representative gave a presentation on her organization’s recent updates regarding drug supply chain rules and regulations.

A recent study found that with greater depression severity, metabolic and clinical characteristics such as HbA1c, fasting blood glucose, and triglyceride levels increased.

Pharmacy law experts detailed the Drug Supply Chain Security Act, highlighting the role each entity within the supply chain plays in ensuring the safety and authenticity of US prescription drugs.

High copayments can be a structural barrier to medication therapy adherence.

Cassandra Esperant, PharmD, AAHIVP, leverages her expertise as a clinical pharmacist to advocate for the well-being of individuals with HIV.